BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 23933934)

  • 41. Changes in spleen volume after resection of hepatic colorectal metastases.
    Jacobs KE; Visser BC; Gayer G
    Clin Radiol; 2012 Oct; 67(10):982-7. PubMed ID: 22608244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bevacizumab Associated with Chemotherapy for Initially Non-resectable Liver Metastases from Colorectal Cancer: a Case-Control Study.
    Alt M; Truant S; Renaud-Vantroys T; Séquier C; Duhamel A; El Amrany M; Turpin A; Makhloufi S; Pruvot FR; Hebbar M
    Anticancer Res; 2016 Oct; 36(10):5551-5555. PubMed ID: 27798929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetic Changes in Liver Parenchyma After Preoperative Chemotherapy for Patients with Colorectal Liver Metastases.
    Tani K; Shindoh J; Takamoto T; Shibahara J; Nishioka Y; Hashimoto T; Sakamoto Y; Hasegawa K; Makuuchi M; Kokudo N
    J Gastrointest Surg; 2017 May; 21(5):813-821. PubMed ID: 28083837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic failure to operate on colorectal cancer liver metastases in California.
    Raoof M; Jutric Z; Haye S; Ituarte PHG; Zhao B; Singh G; Melstrom L; Warner SG; Clary B; Fong Y
    Cancer Med; 2020 Sep; 9(17):6256-6267. PubMed ID: 32687265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative chemotherapy in colorectal cancer patients with synchronous liver metastasis.
    Ichikawa N; Kamiyama T; Yokoo H; Homma S; Maeda Y; Shinohara T; Tsuruga Y; Kazui K; Iijima H; Yoshida T; Taketomi A
    Mol Clin Oncol; 2020 Apr; 12(4):374-383. PubMed ID: 32190322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis.
    Aquina CT; Brown ZJ; Beane JD; Ejaz A; Cloyd JM; Tsung A; Adam MO; Pawlik TM; Kim AC
    Ann Surg Oncol; 2023 Jan; 30(1):335-344. PubMed ID: 36149611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor enhancement of colorectal liver metastases on preoperative gadobutrol-enhanced MRI at 5 minutes post-contrast injection is associated with overall survival post-hepatectomy.
    Cheung HMC; Karanicolas PJ; Coburn N; Law C; Milot L
    Quant Imaging Med Surg; 2019 Feb; 9(2):312-317. PubMed ID: 30976555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases.
    Rada M; Krzywon L; Petrillo S; Lazaris A; Metrakos P
    Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natural Language Processing of Large-Scale Structured Radiology Reports to Identify Oncologic Patients With or Without Splenomegaly Over a 10-Year Period.
    Sun S; Lupton K; Batch K; Nguyen H; Gazit L; Gangai N; Cho J; Nicholas K; Zulkernine F; Sevilimedu V; Simpson A; Do RKG
    JCO Clin Cancer Inform; 2022 Jan; 6():e2100104. PubMed ID: 34990210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Surgical treatment of liver metastases from colorectal cancer patient selection and oncological outcome].
    Moriya Y; Fujita S; Akasu T; Shimada K; Yamamoto J; Kosuge T; Yamasaki S
    Nihon Geka Gakkai Zasshi; 2001 May; 102(5):385-9. PubMed ID: 11394001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A splenic volume increase due to preoperative chemotherapy may impair the long-term outcome after hepatectomy in patients with initially non-optimally resectable colorectal cancer liver metastases.
    Katayama M; Nakano H; Kishi S; Kobayashi S; Koizumi S; Fukunaga T; Miyajima N; Otsubo T
    Hepatogastroenterology; 2013 Sep; 60(126):1420-5. PubMed ID: 23933934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer.
    Simpson AL; Leal JN; Pugalenthi A; Allen PJ; DeMatteo RP; Fong Y; Gönen M; Jarnagin WR; Kingham TP; Miga MI; Shia J; Weiser MR; D'Angelica MI
    J Am Coll Surg; 2015 Mar; 220(3):271-80. PubMed ID: 25617913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
    Reddy SK; Tsung A; Marsh JW; Geller DA
    J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of perioperative chemotherapy in patients with colorectal cancer undergoing hepatectomy for resectable synchronous liver metastasis.
    Nakanishi M; Kuriu Y; Murayama Y; Konishi H; Komatsu S; Shiozaki A; Ikoma H; Kubota T; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Otsuji E
    Hepatogastroenterology; 2014 Sep; 61(134):1582-7. PubMed ID: 25436346
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.